Emkay Global Financial Services is bullish on Sun Pharmaceutical Industries and has recommended accumulate rating on the stock with a target price of Rs 586 in its February 13, 2012 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!